Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to examine whether vitamin D deficiency is differentially associated with multiple metabolic biomarkers in a nationally representative sample of older adults.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were included if they had available data on serum vitamin D levels and all relevant metabolic biomarkers.

Source: Methods.

The present study was based on a secondary analysis of publicly available KNHANES data collected in 2024 and released in December 2025.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Association Between Vitamin D Deficiency and Glycemic, Lipid, and Adiposity Markers in Older Adults: A Nationally Representative Study

Secondary analysis · Metabolites · 2026

Original publication title

Association Between Vitamin D Deficiency and Glycemic, Lipid, and Adiposity Markers in Older Adults: A Nationally Representative Study

Yong-Joon Kim; Kyeongmin Jang

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D deficiency was independently associated with higher HbA1c, triglyceride levels, and waist circumference in older adults, but not with fasting glucose, HDL-cholesterol, C-reactive protein, or body mass index after adjustment. These findings suggest that the associations between vitamin D deficiency and metabolic markers in older adults may differ according to the specific biomarker examined. Future longitudinal and interventional studies are needed to clarify the directionality and underlying mechanisms of these associations.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Cardiometabolic disorders, including diabetes, dyslipidemia, and central obesity, are major contributors to morbidity and mortality in older adults [1,2]. With rapid population aging, the burden of these conditions has increased substantially, particularly among community-dwelling older individuals [2,3]. These metabolic abnormalities frequently coexist and share common pathophysiological mechanisms, including insulin resistance, chronic low-grade inflammation, and dysregulated lipid metabolism, which collectively increase the risk of cardiovascular disease and mortality [4,5].

Vitamin D, traditionally recognized for its role in calcium homeostasis and bone metabolism, has increasingly been identified as a pleiotropic regulator of metabolic health [6]. Vitamin D receptors are widely distributed in pancreatic β-cells, adipose tissue, and skeletal muscle, suggesting a broader role in glucose and lipid metabolism. Experimental and clinical evidence indicates that vitamin D enhances insulin secretion, improves insulin sensitivity, and modulates inflammatory pathways, thereby influencing cardiometabolic homeostasis [6]. In addition, vitamin D has been shown to regulate adipogenesis and adipocyte function, linking it to obesity-related metabolic disturbances [7].

Accordingly, vitamin D deficiency has been associated with multiple metabolic abnormalities implicated in cardiometabolic disease [6].

A growing body of epidemiological research has explored the association between vitamin D status and cardiometabolic risk factors. Recent studies suggest that lower circulating 25-hydroxyvitamin D levels are associated with an increased risk of type 2 diabetes and adverse cardiometabolic profiles, including obesity and dyslipidemia [8]. Population-based studies have further reported inverse associations between vitamin D levels and metabolic syndrome, particularly with respect to abdominal obesity and elevated triglycerides [9]. In Korean adults, recent evidence has also shown that vitamin D status is related to cardiometabolic risk clustering and inflammatory burden, further supporting its potential role in metabolic health [10].

In addition, observational findings indicate that vitamin D deficiency is associated with insulin resistance, a central feature of metabolic dysregulation [11].

Despite these findings, the relationship between vitamin D and cardiometabolic health remains inconsistent. Some interventional and meta-analytic studies have reported modest improvements in glycemic control and lipid profiles following vitamin D supplementation, including reductions in HbA1c and triglyceride levels [12]. However, other studies have found limited or no significant effects on glycemic outcomes, lipid metabolism, or adiposity after accounting for confounding factors such as obesity, lifestyle, and baseline vitamin D status [13]. These inconsistencies may reflect heterogeneity in study populations, differences in study design, and the complex interplay between vitamin D and metabolic pathways.

Another limitation of the existing literature is that many studies have focused on individual metabolic outcomes rather than evaluating multiple biomarkers simultaneously. Cardiometabolic risk is a multidimensional construct involving glucose regulation, lipid metabolism, inflammation, and adiposity. Therefore, examining these domains together may provide a more comprehensive understanding of the metabolic role of vitamin D. In addition, relatively few studies have used nationally representative datasets with appropriate complex sampling designs, particularly in older populations, limiting the generalizability of findings. Older adults represent a high-risk group with both an increased prevalence of vitamin D deficiency and greater susceptibility to metabolic disorders, yet remain underrepresented in many large-scale analyses.

Therefore, this study aimed to examine the association between vitamin D deficiency and multiple metabolic biomarkers, including glycemic, lipid, inflammatory, and anthropometric indicators, in a nationally representative sample of older adults. Older adults were specifically targeted because they represent a high-risk group with both a higher prevalence of vitamin D deficiency and an increased burden of cardiometabolic disorders. In addition, age-related physiological changes, such as reduced cutaneous synthesis of vitamin D and alterations in body composition, may influence both vitamin D status and metabolic health.

By applying complex sample analyses to population-based data, this study sought to provide a comprehensive evaluation of these associations and to clarify the relationship between vitamin D deficiency and key metabolic pathways in older populations.

Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction

Study methods

What methods does the paper describe?

2.1. Study Design and Data Source

This study employed a cross-sectional design using data from the Korea National Health and Nutrition Examination Survey (KNHANES). The dataset used in this study was collected in 2024 and released in December 2025. KNHANES is a nationally representative surveillance system of the non-institutionalized Korean population and has been conducted as an annual survey using a complex, multistage probability sampling design to generate nationally representative health and nutrition statistics in Republic of Korea. More recent overviews have also highlighted the continued expansion and public availability of KNHANES data resources [14].

KNHANES collects data through standardized health interviews, health examinations, and laboratory tests conducted by trained personnel. In the present study, all variables were extracted from the KNHANES dataset. Sociodemographic characteristics and health behavior variables were obtained from self-reported questionnaires, whereas anthropometric measures and metabolic biomarkers were based on direct physical examination and laboratory assessment.

2.2. Study Participants

Among the 6997 participants included in the 2024 KNHANES dataset, individuals aged 65 years or older were considered eligible for this study (n = 1951). Participants were included if they had available data on serum vitamin D levels and all relevant metabolic biomarkers. Individuals with missing values for key variables, including vitamin D, metabolic biomarkers, or covariates, were excluded from the analysis. After applying these criteria, a total of 1806 participants were included in the final analytic sample. All analyses incorporated sampling weights to account for the complex survey design and to ensure nationally representative estimates.

2.3. Vitamin D Status

The main independent variable was vitamin D status. Serum vitamin D concentration was assessed using 25-hydroxyvitamin D [25(OH)D], which is the accepted biomarker for evaluating vitamin D status. Vitamin D deficiency was defined as a serum 25(OH)D level < 20 ng/mL. This threshold remains widely used in recent vitamin D literature, although recent guidelines have noted that the optimal target concentration for disease prevention remains under debate. Participants were categorized into vitamin D-deficient and non-deficient groups accordingly [15].

2.4. Metabolic Biomarkers

The dependent variables included fasting glucose (mg/dL), glycated hemoglobin (HbA1c, %), triglycerides (mg/dL), C-reactive protein (CRP, mg/L), high-density lipoprotein cholesterol (HDL-C, mg/dL), waist circumference (cm), and body mass index (BMI, kg/m2). Laboratory biomarkers were obtained from blood samples collected and analyzed by KNHANES using standardized procedures, and fasting glucose and triglycerides were based on fasting blood samples. Anthropometric variables, including waist circumference, height, and weight, were measured directly by trained personnel using standardized protocols. BMI was calculated as weight in kilograms divided by height in meters squared.

These biomarkers are commonly used indicators of metabolic and cardiometabolic risk in older adults. Because triglycerides and C-reactive protein exhibited skewed distributions, natural logarithmic transformation was applied prior to analysis to improve normality.

2.5. Covariates

Covariates included sociodemographic characteristics, health behaviors, and comorbid conditions. Sociodemographic variables included age (years), sex (male/female), residence (urban/rural), household income, and education level. Residence was categorized as urban or rural based on administrative classification. Household income was categorized into quartiles (Q1: Q4) based on the KNHANES household income quartile variable, which is derived from monthly equivalized household income (monthly household income divided by the square root of household size). Education level was categorized as ≤elementary school, middle school, high school, or ≥college.

Health behavior variables included monthly alcohol consumption, current smoking status, and aerobic physical activity. These variables were assessed using self-reported questionnaires. Monthly alcohol consumption was defined as drinking alcohol at least once per month (yes/no), and current smoking status was categorized as yes or no. Aerobic physical activity was defined according to KNHANES guidelines as engaging in at least 150 min of moderate-intensity physical activity or 75 min of vigorous-intensity physical activity per week, or an equivalent combination of both.

Comorbidities included hypertension and diabetes mellitus, which were defined based on physician diagnosis, current treatment, or standardized KNHANES criteria. These variables were selected as potential confounders based on previous studies demonstrating their associations with both vitamin D status and metabolic risk [16,17].

Obesity: and inflammation-related variables, including body mass index, waist circumference, and C-reactive protein, were not included as covariates because they were analyzed as outcome variables in this study. Including these variables as covariates could result in over-adjustment and potentially obscure the associations of interest.

2.6. Statistical Analysis

All statistical analyses were performed using IBM SPSS Statistics (version 29.0, IBM Corp., Armonk, NY, USA), applying complex sample design procedures to account for the stratification, clustering, and sampling weights of KNHANES. These procedures were used to generate nationally representative estimates and appropriate standard errors reflecting the multistage probability sampling design. Descriptive statistics were presented as weighted percentages with standard errors (SE) for categorical variables and weighted means with SE for continuous variables. Differences in participant characteristics according to vitamin D status were assessed using the Rao: Scott chi-square test for categorical variables and complex sample general linear models for continuous variables.

To examine the association between vitamin D status and metabolic biomarkers, complex sample linear regression analyses were conducted, with vitamin D status included as a dichotomous independent variable (deficient vs. non-deficient) and metabolic biomarkers treated as continuous dependent variables. Model 1 was unadjusted. Model 2 was adjusted for sociodemographic variables (age, sex, residence, household income, and education level). Model 3 was additionally adjusted for health behaviors (smoking, alcohol consumption, and aerobic physical activity) and comorbidities (hypertension and diabetes mellitus). The results were presented as β coefficients, 95% confidence intervals (CI), and p-values.

Statistical significance was set at p < 0.05.

2.7. Ethical Considerations

KNHANES was conducted by the Korea Disease Control and Prevention Agency (KDCA) in accordance with the Declaration of Helsinki and was approved by the KDCA Institutional Review Board (IRB No. 2022-11-16-R-03). Written informed consent was obtained from all participants during the original survey. The present study was based on a secondary analysis of publicly available KNHANES data collected in 2024 and released in December 2025. Because the dataset was fully de-identified and contained no personally identifiable information, additional institutional review board approval was not required for this study.

Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods

Results: General Characteristics of Participants

The general characteristics of the study population are presented in Table 1. A total of 1806 older adults were included, with a mean age of 72.78 ± 0.18 years. Women accounted for 54.0% of the sample, and 73.8% resided in urban areas. Socioeconomically, 37.2% were in the lowest household income quartile, and 43.1% had an education level of elementary school or lower. In terms of health behaviors, 64.7% reported no monthly alcohol consumption, 91.9% were non-smokers, and 67.6% did not engage in aerobic physical activity.

The prevalence of hypertension and diabetes mellitus was 54.0% and 24.8%, respectively. The mean serum vitamin D level was 29.88 ± 0.38 ng/mL. The mean fasting glucose level was 107.42 ± 0.57 mg/dL, and the mean HbA1c was 5.97 ± 0.02%. The mean HDL-cholesterol level was 56.41 ± 0.41 mg/dL, and the mean waist circumference was 85.69 ± 0.27 cm (Table 1).

Table 1

General characteristics of participants (n = 1806).

VariableCategory n Weighted % or Mean ± SE95% CI
Sociodemographic
Age, yearsNot reported180672.78 ± 0.1872.43 to 73.14
SexMale76046.0 ± 1.143.9 to 48.1
Female104654.0 ± 1.151.9 to 56.1
ResidenceUrban127373.8 ± 3.666.0 to 80.4
Rural53326.2 ± 3.619.6 to 34.0
Household incomeQ1 (lowest)73737.2 ± 1.833.8 to 40.8
Q253731.4 ± 1.528.5 to 34.5
Q334820.2 ± 1.417.5 to 23.2
Q4 (highest)18411.2 ± 1.09.3 to 13.4
Education level≤Elementary80343.1 ± 1.739.8 to 46.5
Middle37320.5 ± 1.118.5 to 22.7
High41224.0 ± 1.221.7 to 26.5
≥College21812.4 ± 1.210.1 to 15.0
Health behaviors
Monthly drinkingNo118664.7 ± 1.461.9 to 67.5
Yes62035.3 ± 1.432.5 to 38.1
Current smokingNo162991.9 ± 0.790.3 to 93.2
Yes1778.1 ± 0.76.8 to 9.7
Aerobic physical activityNo121867.6 ± 1.764.1 to 70.9
Yes58832.4 ± 1.729.1 to 35.9
Comorbidities
HypertensionNo82346.0 ± 1.343.3 to 48.6
Yes98354.0 ± 1.351.3 to 56.6
Diabetes mellitusNo135875.1 ± 1.172.9 to 77.2
Yes44824.8 ± 1.122.8 to 27.0
Metabolic and clinical variables
Vitamin D, ng/mLNot reported180629.88 ± 0.3829.13 to 30.64
Fasting glucose, mg/dLNot reported1806107.42 ± 0.57106.30 to 108.54
HbA1c, %Not reported18065.97 ± 0.025.92 to 6.01
ln (Triglycerides)Not reported18064.68 ± 0.014.66 to 4.71
ln (C-reactive protein)Not reported1806−0.51 ± 0.03−0.56 to −0.46
HDL-cholesterol, mg/dLNot reported180656.41 ± 0.4155.60 to 57.21
Waist circumference, cmNot reported180685.69 ± 0.2785.17 to 86.21
Body mass index, kg/m2Not reported180624.07 ± 0.0923.90 to 24.24

Note. Values are presented as weighted percentages with standard errors (SE) for categorical variables and weighted means with SE for continuous variables, along with 95% confidence intervals (CI), using a complex sample design. Unweighted frequencies are presented as n. Household income quartiles were defined according to the 2024 KNHANES household income quartile criteria based on monthly equivalized household income: Q1, ≤129.64; Q2, 129.65 to 264.89; Q3, 264.90 to 418.34; and Q4, >418.34 (10,000 KRW/month). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values.

Abbreviations: SE, standard error; CI, confidence interval; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Source: 3.1. General Characteristics of Participants Source: 3.1. General Characteristics of Participants

Differences in Characteristics According to Vitamin D Status

Results: Differences in Characteristics According to Vitamin D Status

Among the study population, 409 participants (22.6%) were classified as vitamin D deficient. Differences in participant characteristics according to vitamin D status are presented in Table 2. Compared with participants without vitamin D deficiency, those with deficiency were older and more likely to be male. They also had a higher prevalence of current smoking and diabetes mellitus and were less likely to engage in aerobic physical activity. In terms of metabolic profiles, participants with vitamin D deficiency showed less favorable profiles, including higher fasting glucose, HbA1c, triglycerides, and waist circumference, as well as lower HDL-cholesterol levels.

No significant differences were observed for residence, household income, education level, monthly alcohol consumption, hypertension, or body mass index.

Table 2

Comparison of characteristics according to vitamin D status.

VariableCategoryDeficient
(<20 ng/mL,
n = 409)
Non-Deficient
(≥20 ng/mL,
n = 1397)
F p
Sociodemographic factors
Age, yearsNot reported73.37 ± 0.3472.61 ± 0.184.960.026
SexMale63.4 (1.8)40.9 (1.2)55.35<0.001
Female36.6 (1.8)59.1 (1.2)
ResidenceUrban74.7 (2.0)73.6 (1.4)0.100.748
Rural25.3 (2.0)26.4 (1.4)
Household incomeQ138.4 (2.5)36.9 (1.7)0.550.643
Q232.4 (2.2)31.1 (1.5)
Q317.7 (1.7)20.9 (1.3)
Q411.5 (1.3)11.1 (1.0)
Education level≤Elementary43.0 (2.4)43.1 (1.6)0.330.788
Middle19.0 (1.8)20.9 (1.3)
High24.3 (2.0)23.9 (1.4)
≥College13.7 (1.5)12.0 (1.0)
Health behaviors
Monthly drinkingNo61.0 (2.4)65.8 (1.5)2.570.111
Yes39.0 (2.4)34.2 (1.5)
Current smokingNo85.4 (1.7)93.8 (0.8)22.77<0.001
Yes14.6 (1.7)6.2 (0.8)
Aerobic physical activityNo73.7 (2.1)65.9 (1.6)5.480.020
Yes26.3 (2.1)34.1 (1.6)
Comorbidities
HypertensionNo45.7 (2.4)46.1 (1.6)0.130.872
Yes54.3 (2.4)53.9 (1.6)
Diabetes mellitusNo72.1 (2.1)76.1 (1.3)3.270.040
Yes27.9 (2.1)23.9 (1.3)
Metabolic and clinical variables
Waist circumference, cmNot reported87.26 ± 0.6485.23 ± 0.3111.65<0.001
Body mass index, kg/m2Not reported24.27 ± 0.1524.01 ± 0.102.210.139
HDL-cholesterol, mg/dLNot reported52.01 ± 0.7757.69 ± 0.4839.58<0.001
Fasting glucose, mg/dLNot reported110.68 ± 1.46106.47 ± 0.616.700.010
HbA1c, %Not reported6.08 ± 0.055.93 ± 0.028.500.004
ln (Triglycerides)Not reported4.79 ± 0.034.66 ± 0.0115.00<0.001
ln (C-reactive protein)Not reported−0.31 ± 0.06−0.57 ± 0.0316.00<0.001

Note. Values are presented as weighted percentages (SE) for categorical variables and weighted means (SE) for continuous variables. The Rao: Scott chi-square test (reported as adjusted F statistics) was used for categorical variables, and complex samples general linear models were used for continuous variables. Household income quartiles were defined according to the 2024 KNHANES household income quartile criteria based on monthly equivalized household income: Q1, ≤129.64; Q2, 129.65 to 264.89; Q3, 264.90 to 418.34; and Q4, >418.34 (10,000 KRW/month). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values.

Abbreviations: HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Source: 3.2. Differences in Characteristics According to Vitamin D Status Source: 3.2. Differences in Characteristics According to Vitamin D Status

Association Between Vitamin D Deficiency and Metabolic Biomarkers

Results: Association Between Vitamin D Deficiency and Metabolic Biomarkers

The associations between vitamin D deficiency and metabolic biomarkers are presented in Table 3. In the unadjusted model, vitamin D deficiency was associated with higher levels of fasting glucose, HbA1c, triglycerides, and waist circumference, and with lower HDL-cholesterol levels. After adjustment for sociodemographic factors, the associations remained significant for HbA1c, triglycerides, and waist circumference, whereas those for fasting glucose and HDL-cholesterol were attenuated. In the fully adjusted model, vitamin D deficiency remained significantly associated with higher HbA1c (β = 0.10, 95% CI: 0.01 to 0.20, p = 0.034), higher triglyceride levels (β = 0.10, 95% CI: 0.04 to 0.17, p = 0.003), and greater waist circumference (β = 1.21, 95% CI: 0.06 to 2.37, p = 0.040).

No significant associations were observed for fasting glucose, HDL-cholesterol, C-reactive protein, or body mass index. Detailed regression coefficients are presented in Table 3.

Table 3

Association between vitamin D deficiency and metabolic biomarkers in older adults.

OutcomeModel 1
β (95% CI)
p Model 2
β (95% CI)
p Model 3
β (95% CI)
p
Fasting glucose (mg/dL)4.21 (1.04, 7.39)0.0102.87 (−0.34, 6.07)0.0792.17 (−1.01, 5.35)0.180
HbA1c (%)0.15 (0.05, 0.25)0.0040.14 (0.04, 0.24)0.0080.10 (0.01, 0.20)0.034
ln (Triglycerides)0.13 (0.07, 0.19)<0.0010.12 (0.06, 0.19)<0.0010.10 (0.04, 0.17)0.003
ln (C-reactive protein)0.06 (−0.03, 0.15)0.1960.05 (−0.04, 0.14)0.2760.04 (−0.05, 0.13)0.391
HDL-cholesterol (mg/dL)−1.87 (−3.22, −0.52)0.007−1.21 (−2.58, 0.16)0.083−0.89 (−2.21, 0.43)0.186
Waist circumference (cm)2.03 (0.85, 3.20)<0.0011.54 (0.36, 2.72)0.0111.21 (0.06, 2.37)0.040
Body mass index (kg/m2)0.25 (−0.08, 0.59)0.1390.19 (−0.15, 0.52)0.2730.12 (−0.21, 0.45)0.471

Note. Model 1 was unadjusted. Model 2 was adjusted for age, sex, residence, household income, and education level. Model 3 was additionally adjusted for smoking, alcohol consumption, aerobic physical activity, hypertension, and diabetes mellitus. β coefficients represent differences in metabolic biomarker levels for participants with vitamin D deficiency (<20 ng/mL) compared with those without deficiency (≥20 ng/mL). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values. All analyses were conducted using complex sample design procedures.

Abbreviations: CI, confidence interval; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Source: 3.3. Association Between Vitamin D Deficiency and Metabolic Biomarkers Source: 3.3. Association Between Vitamin D Deficiency and Metabolic Biomarkers

Discussion

This study aimed to examine the association between vitamin D deficiency and multiple metabolic biomarkers in a nationally representative sample of older adults. The main findings showed that vitamin D deficiency remained independently associated with higher HbA1c, triglyceride levels, and waist circumference after full adjustment, whereas the associations with fasting glucose, HDL-cholesterol, C-reactive protein, and body mass index were no longer significant. These findings suggest that the metabolic correlates of vitamin D deficiency in later life may be selective rather than uniform across cardiometabolic markers.

In particular, vitamin D deficiency appeared to be more closely related to markers of long-term glycemic control, triglyceride metabolism, and central adiposity than to other metabolic domains.

One notable finding was that vitamin D deficiency remained associated with HbA1c, but not with fasting glucose, in the fully adjusted model. This distinction suggests that vitamin D status may be more closely related to long-term glycemic regulation than to short-term glucose fluctuations. This interpretation is supported by recent intervention evidence showing that vitamin D supplementation can improve glycemic control in type 2 diabetes, including HbA1c-related outcomes, although the magnitude of benefit varies across studies [18]. In addition, an updated 2024 systematic review and meta-analysis in older adults reported that low 25(OH)D was associated with incident diabetes even after adjustment for relevant confounders, supporting the view that low vitamin D status is linked to poorer long-term glycemic health in aging populations [19].

From a pathophysiological perspective, vitamin D may influence chronic glycemic status through its role in pancreatic β-cell function, calcium-mediated insulin secretion, and systemic insulin sensitivity [20]. In contrast, fasting glucose is a single-time-point measure and may be more sensitive to recent metabolic conditions, fasting-related variability, and circadian timing than HbA1c [21]. HbA1c, by contrast, reflects average glycemic exposure over approximately 8 to 12 weeks [22]. Therefore, the discrepancy observed in the present study may reflect differences in the temporal characteristics of glycemic markers rather than inconsistency in biological effects.

Taken together, the present HbA1c finding appears consistent with prior evidence. In contrast, the null finding for fasting glucose may indicate that vitamin D status is more closely related to cumulative glycemic exposure than to a single fasting measurement. Given the clinical importance of glycemic control in older adults, the observed association with HbA1c may be clinically meaningful [23].

The association with triglycerides is also consistent with previous findings. A 2024 systematic review and meta-analysis of randomized controlled trials in people with type 2 diabetes concluded that vitamin D supplementation improved triglyceride and HDL levels, while not significantly improving LDL or total cholesterol [24]. Likewise, a 2025 meta-analysis in overweight or obese women reported a significant effect of vitamin D supplementation on hypertriglyceridemia, but not on LDL-C [25]. In the present study, however, only triglycerides remained significant after full adjustment, whereas HDL-cholesterol did not.

This divergence suggests that vitamin D deficiency may be preferentially linked to triglyceride metabolism rather than to all lipid fractions. Mechanistically, triglycerides are closely associated with insulin resistance and hepatic lipid synthesis, both of which have been proposed as pathways influenced by vitamin D status. In contrast, HDL-cholesterol is affected by a broader range of genetic, hormonal, and lifestyle factors, which may attenuate its independent association with vitamin D after adjustment. Therefore, the present findings support a more targeted interpretation of vitamin D in lipid metabolism, emphasizing its potential role in triglyceride regulation.

Another important finding was that vitamin D deficiency was associated with waist circumference, but not with body mass index, after adjustment. This distinction highlights the need to differentiate between central adiposity and general obesity in older populations. A 2025 cross-sectional study in older adults demonstrated that serum vitamin D levels were inversely associated with visceral adipose tissue mass, a metabolically active fat compartment strongly linked to insulin resistance and cardiometabolic risk [26]. That study further reported attenuation of the association after adjustment, indicating that adiposity-related relationships are influenced by multiple confounding variables [26].

In the present study, the persistence of waist circumference but not BMI suggests that vitamin D deficiency may be more closely related to abdominal fat distribution than to overall body mass. This finding is particularly relevant in older adults, where age-related changes such as sarcopenia and fat redistribution may limit the interpretability of BMI. Waist circumference, as a marker of central adiposity, may therefore provide a more sensitive indicator of metabolically relevant fat accumulation in this population.

By contrast, the loss of significance for fasting glucose, HDL-cholesterol, and C-reactive protein after multivariable adjustment suggests that the crude associations observed in unadjusted analyses were at least partly explained by confounding variables. Factors such as age, physical activity, smoking, and comorbid conditions are known to influence both vitamin D status and metabolic health, and their inclusion in the adjusted models likely reduced spurious associations. This interpretation is consistent with recent literature showing that vitamin D supplementation may influence inflammatory markers in specific populations rather than uniformly across all adults [27].

Therefore, the absence of an independent association with C-reactive protein in the present study should be interpreted cautiously and may reflect the influence of confounding factors rather than the absence of any relationship. The lack of significant associations for several biomarkers after full adjustment further suggests that the crude relationships observed in unadjusted analyses may have been influenced by confounding factors, highlighting the importance of appropriate adjustment in epidemiological studies.

The cross-sectional design of this study requires cautious interpretation of the observed associations. A 2025 bidirectional two-sample Mendelian randomization study found no evidence that circulating 25(OH)D is linked to metabolic syndrome traits in a directional manner; instead, it suggested that vitamin D status and metabolic traits such as waist circumference, BMI, and triglycerides may be interrelated [28]. This finding is relevant to the present study, as it suggests that the observed associations may reflect complex or bidirectional relationships rather than a simple one-way pathway between vitamin D deficiency and metabolic dysfunction.

Taken together, these findings suggest that vitamin D deficiency may be linked to specific aspects of metabolic dysregulation: particularly long-term glycemic control, triglyceride metabolism, and central adiposity: while other associations may be partly influenced by confounding variables. This domain-specific pattern may help explain the heterogeneity observed in previous studies and highlights the need for more targeted investigation of vitamin D-related metabolic pathways. In addition, renal function, which plays an important role in vitamin D metabolism, was not included in the present analysis; therefore, residual confounding variables cannot be excluded.

Furthermore, seasonal variation in vitamin D levels was not explicitly accounted for in this study. Although KNHANES employs a year-round rolling survey design, differences in sunlight exposure across seasons may have influenced serum vitamin D concentrations, and thus residual confounding variables related to seasonality may remain. Future studies incorporating kidney function indicators and seasonal adjustment are warranted to better clarify these relationships.

Overall, the present findings should be interpreted cautiously. In this nationally representative sample of older adults, vitamin D deficiency was independently associated with HbA1c, triglycerides, and waist circumference, but not with fasting glucose, HDL-cholesterol, C-reactive protein, or body mass index after full adjustment. These findings are consistent with previous evidence suggesting that the associations between vitamin D deficiency and metabolic markers may differ according to the specific outcome examined.

Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion

Results

3.1. General Characteristics of Participants

The general characteristics of the study population are presented in Table 1. A total of 1806 older adults were included, with a mean age of 72.78 ± 0.18 years. Women accounted for 54.0% of the sample, and 73.8% resided in urban areas. Socioeconomically, 37.2% were in the lowest household income quartile, and 43.1% had an education level of elementary school or lower. In terms of health behaviors, 64.7% reported no monthly alcohol consumption, 91.9% were non-smokers, and 67.6% did not engage in aerobic physical activity.

The prevalence of hypertension and diabetes mellitus was 54.0% and 24.8%, respectively. The mean serum vitamin D level was 29.88 ± 0.38 ng/mL. The mean fasting glucose level was 107.42 ± 0.57 mg/dL, and the mean HbA1c was 5.97 ± 0.02%. The mean HDL-cholesterol level was 56.41 ± 0.41 mg/dL, and the mean waist circumference was 85.69 ± 0.27 cm (Table 1).

3.2. Differences in Characteristics According to Vitamin D Status

Among the study population, 409 participants (22.6%) were classified as vitamin D deficient. Differences in participant characteristics according to vitamin D status are presented in Table 2. Compared with participants without vitamin D deficiency, those with deficiency were older and more likely to be male. They also had a higher prevalence of current smoking and diabetes mellitus and were less likely to engage in aerobic physical activity. In terms of metabolic profiles, participants with vitamin D deficiency showed less favorable profiles, including higher fasting glucose, HbA1c, triglycerides, and waist circumference, as well as lower HDL-cholesterol levels.

No significant differences were observed for residence, household income, education level, monthly alcohol consumption, hypertension, or body mass index.

3.3. Association Between Vitamin D Deficiency and Metabolic Biomarkers

The associations between vitamin D deficiency and metabolic biomarkers are presented in Table 3. In the unadjusted model, vitamin D deficiency was associated with higher levels of fasting glucose, HbA1c, triglycerides, and waist circumference, and with lower HDL-cholesterol levels. After adjustment for sociodemographic factors, the associations remained significant for HbA1c, triglycerides, and waist circumference, whereas those for fasting glucose and HDL-cholesterol were attenuated. In the fully adjusted model, vitamin D deficiency remained significantly associated with higher HbA1c (β = 0.10, 95% CI: 0.01 to 0.20, p = 0.034), higher triglyceride levels (β = 0.10, 95% CI: 0.04 to 0.17, p = 0.003), and greater waist circumference (β = 1.21, 95% CI: 0.06 to 2.37, p = 0.040).

No significant associations were observed for fasting glucose, HDL-cholesterol, C-reactive protein, or body mass index. Detailed regression coefficients are presented in Table 3.

Table 1

General characteristics of participants (n = 1806).

VariableCategory n Weighted % or Mean ± SE95% CI
Sociodemographic
Age, yearsNot reported180672.78 ± 0.1872.43 to 73.14
SexMale76046.0 ± 1.143.9 to 48.1
Female104654.0 ± 1.151.9 to 56.1
ResidenceUrban127373.8 ± 3.666.0 to 80.4
Rural53326.2 ± 3.619.6 to 34.0
Household incomeQ1 (lowest)73737.2 ± 1.833.8 to 40.8
Q253731.4 ± 1.528.5 to 34.5
Q334820.2 ± 1.417.5 to 23.2
Q4 (highest)18411.2 ± 1.09.3 to 13.4
Education level≤Elementary80343.1 ± 1.739.8 to 46.5
Middle37320.5 ± 1.118.5 to 22.7
High41224.0 ± 1.221.7 to 26.5
≥College21812.4 ± 1.210.1 to 15.0
Health behaviors
Monthly drinkingNo118664.7 ± 1.461.9 to 67.5
Yes62035.3 ± 1.432.5 to 38.1
Current smokingNo162991.9 ± 0.790.3 to 93.2
Yes1778.1 ± 0.76.8 to 9.7
Aerobic physical activityNo121867.6 ± 1.764.1 to 70.9
Yes58832.4 ± 1.729.1 to 35.9
Comorbidities
HypertensionNo82346.0 ± 1.343.3 to 48.6
Yes98354.0 ± 1.351.3 to 56.6
Diabetes mellitusNo135875.1 ± 1.172.9 to 77.2
Yes44824.8 ± 1.122.8 to 27.0
Metabolic and clinical variables
Vitamin D, ng/mLNot reported180629.88 ± 0.3829.13 to 30.64
Fasting glucose, mg/dLNot reported1806107.42 ± 0.57106.30 to 108.54
HbA1c, %Not reported18065.97 ± 0.025.92 to 6.01
ln (Triglycerides)Not reported18064.68 ± 0.014.66 to 4.71
ln (C-reactive protein)Not reported1806−0.51 ± 0.03−0.56 to −0.46
HDL-cholesterol, mg/dLNot reported180656.41 ± 0.4155.60 to 57.21
Waist circumference, cmNot reported180685.69 ± 0.2785.17 to 86.21
Body mass index, kg/m2Not reported180624.07 ± 0.0923.90 to 24.24

Note. Values are presented as weighted percentages with standard errors (SE) for categorical variables and weighted means with SE for continuous variables, along with 95% confidence intervals (CI), using a complex sample design. Unweighted frequencies are presented as n. Household income quartiles were defined according to the 2024 KNHANES household income quartile criteria based on monthly equivalized household income: Q1, ≤129.64; Q2, 129.65 to 264.89; Q3, 264.90 to 418.34; and Q4, >418.34 (10,000 KRW/month). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values.

Abbreviations: SE, standard error; CI, confidence interval; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Table 2

Comparison of characteristics according to vitamin D status.

VariableCategoryDeficient
(<20 ng/mL,
n = 409)
Non-Deficient
(≥20 ng/mL,
n = 1397)
F p
Sociodemographic factors
Age, yearsNot reported73.37 ± 0.3472.61 ± 0.184.960.026
SexMale63.4 (1.8)40.9 (1.2)55.35<0.001
Female36.6 (1.8)59.1 (1.2)
ResidenceUrban74.7 (2.0)73.6 (1.4)0.100.748
Rural25.3 (2.0)26.4 (1.4)
Household incomeQ138.4 (2.5)36.9 (1.7)0.550.643
Q232.4 (2.2)31.1 (1.5)
Q317.7 (1.7)20.9 (1.3)
Q411.5 (1.3)11.1 (1.0)
Education level≤Elementary43.0 (2.4)43.1 (1.6)0.330.788
Middle19.0 (1.8)20.9 (1.3)
High24.3 (2.0)23.9 (1.4)
≥College13.7 (1.5)12.0 (1.0)
Health behaviors
Monthly drinkingNo61.0 (2.4)65.8 (1.5)2.570.111
Yes39.0 (2.4)34.2 (1.5)
Current smokingNo85.4 (1.7)93.8 (0.8)22.77<0.001
Yes14.6 (1.7)6.2 (0.8)
Aerobic physical activityNo73.7 (2.1)65.9 (1.6)5.480.020
Yes26.3 (2.1)34.1 (1.6)
Comorbidities
HypertensionNo45.7 (2.4)46.1 (1.6)0.130.872
Yes54.3 (2.4)53.9 (1.6)
Diabetes mellitusNo72.1 (2.1)76.1 (1.3)3.270.040
Yes27.9 (2.1)23.9 (1.3)
Metabolic and clinical variables
Waist circumference, cmNot reported87.26 ± 0.6485.23 ± 0.3111.65<0.001
Body mass index, kg/m2Not reported24.27 ± 0.1524.01 ± 0.102.210.139
HDL-cholesterol, mg/dLNot reported52.01 ± 0.7757.69 ± 0.4839.58<0.001
Fasting glucose, mg/dLNot reported110.68 ± 1.46106.47 ± 0.616.700.010
HbA1c, %Not reported6.08 ± 0.055.93 ± 0.028.500.004
ln (Triglycerides)Not reported4.79 ± 0.034.66 ± 0.0115.00<0.001
ln (C-reactive protein)Not reported−0.31 ± 0.06−0.57 ± 0.0316.00<0.001

Note. Values are presented as weighted percentages (SE) for categorical variables and weighted means (SE) for continuous variables. The Rao: Scott chi-square test (reported as adjusted F statistics) was used for categorical variables, and complex samples general linear models were used for continuous variables. Household income quartiles were defined according to the 2024 KNHANES household income quartile criteria based on monthly equivalized household income: Q1, ≤129.64; Q2, 129.65 to 264.89; Q3, 264.90 to 418.34; and Q4, >418.34 (10,000 KRW/month). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values.

Abbreviations: HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Table 3

Association between vitamin D deficiency and metabolic biomarkers in older adults.

OutcomeModel 1
β (95% CI)
p Model 2
β (95% CI)
p Model 3
β (95% CI)
p
Fasting glucose (mg/dL)4.21 (1.04, 7.39)0.0102.87 (−0.34, 6.07)0.0792.17 (−1.01, 5.35)0.180
HbA1c (%)0.15 (0.05, 0.25)0.0040.14 (0.04, 0.24)0.0080.10 (0.01, 0.20)0.034
ln (Triglycerides)0.13 (0.07, 0.19)<0.0010.12 (0.06, 0.19)<0.0010.10 (0.04, 0.17)0.003
ln (C-reactive protein)0.06 (−0.03, 0.15)0.1960.05 (−0.04, 0.14)0.2760.04 (−0.05, 0.13)0.391
HDL-cholesterol (mg/dL)−1.87 (−3.22, −0.52)0.007−1.21 (−2.58, 0.16)0.083−0.89 (−2.21, 0.43)0.186
Waist circumference (cm)2.03 (0.85, 3.20)<0.0011.54 (0.36, 2.72)0.0111.21 (0.06, 2.37)0.040
Body mass index (kg/m2)0.25 (−0.08, 0.59)0.1390.19 (−0.15, 0.52)0.2730.12 (−0.21, 0.45)0.471

Note. Model 1 was unadjusted. Model 2 was adjusted for age, sex, residence, household income, and education level. Model 3 was additionally adjusted for smoking, alcohol consumption, aerobic physical activity, hypertension, and diabetes mellitus. β coefficients represent differences in metabolic biomarker levels for participants with vitamin D deficiency (<20 ng/mL) compared with those without deficiency (≥20 ng/mL). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values. All analyses were conducted using complex sample design procedures.

Abbreviations: CI, confidence interval; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results

Conclusions

Vitamin D deficiency was independently associated with higher HbA1c, triglyceride levels, and waist circumference in older adults, but not with fasting glucose, HDL-cholesterol, C-reactive protein, or body mass index after adjustment. These findings suggest that the associations between vitamin D deficiency and metabolic markers in older adults may differ according to the specific biomarker examined. Future longitudinal and interventional studies are needed to clarify the directionality and underlying mechanisms of these associations.

Source: 5. Conclusions
Authors’ abstract

Background/Objectives: Vitamin D plays an important role in glucose metabolism, lipid regulation, and inflammatory processes, and has been implicated in cardiometabolic health. However, its associations with specific metabolic biomarkers remain inconsistent, particularly in older adults. This study aimed to examine whether vitamin D deficiency is differentially associated with multiple metabolic biomarkers in a nationally representative sample of older adults. Methods: This cross-sectional study used data from the 2024 Korea National Health and Nutrition Examination Survey, including 1806 adults aged ≥65 years.

Vitamin D deficiency was defined as serum 25-hydroxyvitamin D levels < 20 ng/mL. Metabolic biomarkers included fasting glucose, glycated hemoglobin (HbA1c), triglycerides, C-reactive protein (CRP), high-density lipoprotein cholesterol (HDL-C), waist circumference, and body mass index (BMI). Complex sample linear regression analyses were performed with sequential adjustment for sociodemographic factors, health behaviors, and comorbidities. Results: In unadjusted analyses, vitamin D deficiency was associated with adverse metabolic profiles, including higher fasting glucose, HbA1c, triglycerides, waist circumference, and CRP levels, and lower HDL-C levels.

After adjustment for sociodemographic factors, health behaviors, and comorbidities, significant associations remained for HbA1c (β = 0.10, p = 0.034), triglycerides (β = 0.10, p = 0.003), and waist circumference (β = 1.21, p = 0.040). No significant associations were observed for fasting glucose, HDL-C, CRP, or BMI. Conclusions: Vitamin D deficiency was independently associated with poorer long-term glycemic status, hypertriglyceridemia, and central adiposity in older adults, but not with other metabolic markers after adjustment. These findings suggest that the metabolic correlates of vitamin D deficiency may be domain-specific rather than generalized.

Longitudinal and interventional studies are needed to clarify causality and underlying mechanisms.

Read the full paper

1. Introduction

Cardiometabolic disorders, including diabetes, dyslipidemia, and central obesity, are major contributors to morbidity and mortality in older adults [1,2]. With rapid population aging, the burden of these conditions has increased substantially, particularly among community-dwelling older individuals [2,3]. These metabolic abnormalities frequently coexist and share common pathophysiological mechanisms, including insulin resistance, chronic low-grade inflammation, and dysregulated lipid metabolism, which collectively increase the risk of cardiovascular disease and mortality [4,5].

Vitamin D, traditionally recognized for its role in calcium homeostasis and bone metabolism, has increasingly been identified as a pleiotropic regulator of metabolic health [6]. Vitamin D receptors are widely distributed in pancreatic β-cells, adipose tissue, and skeletal muscle, suggesting a broader role in glucose and lipid metabolism. Experimental and clinical evidence indicates that vitamin D enhances insulin secretion, improves insulin sensitivity, and modulates inflammatory pathways, thereby influencing cardiometabolic homeostasis [6]. In addition, vitamin D has been shown to regulate adipogenesis and adipocyte function, linking it to obesity-related metabolic disturbances [7].

Accordingly, vitamin D deficiency has been associated with multiple metabolic abnormalities implicated in cardiometabolic disease [6].

A growing body of epidemiological research has explored the association between vitamin D status and cardiometabolic risk factors. Recent studies suggest that lower circulating 25-hydroxyvitamin D levels are associated with an increased risk of type 2 diabetes and adverse cardiometabolic profiles, including obesity and dyslipidemia [8]. Population-based studies have further reported inverse associations between vitamin D levels and metabolic syndrome, particularly with respect to abdominal obesity and elevated triglycerides [9]. In Korean adults, recent evidence has also shown that vitamin D status is related to cardiometabolic risk clustering and inflammatory burden, further supporting its potential role in metabolic health [10].

In addition, observational findings indicate that vitamin D deficiency is associated with insulin resistance, a central feature of metabolic dysregulation [11].

Despite these findings, the relationship between vitamin D and cardiometabolic health remains inconsistent. Some interventional and meta-analytic studies have reported modest improvements in glycemic control and lipid profiles following vitamin D supplementation, including reductions in HbA1c and triglyceride levels [12]. However, other studies have found limited or no significant effects on glycemic outcomes, lipid metabolism, or adiposity after accounting for confounding factors such as obesity, lifestyle, and baseline vitamin D status [13]. These inconsistencies may reflect heterogeneity in study populations, differences in study design, and the complex interplay between vitamin D and metabolic pathways.

Another limitation of the existing literature is that many studies have focused on individual metabolic outcomes rather than evaluating multiple biomarkers simultaneously. Cardiometabolic risk is a multidimensional construct involving glucose regulation, lipid metabolism, inflammation, and adiposity. Therefore, examining these domains together may provide a more comprehensive understanding of the metabolic role of vitamin D. In addition, relatively few studies have used nationally representative datasets with appropriate complex sampling designs, particularly in older populations, limiting the generalizability of findings. Older adults represent a high-risk group with both an increased prevalence of vitamin D deficiency and greater susceptibility to metabolic disorders, yet remain underrepresented in many large-scale analyses.

Therefore, this study aimed to examine the association between vitamin D deficiency and multiple metabolic biomarkers, including glycemic, lipid, inflammatory, and anthropometric indicators, in a nationally representative sample of older adults. Older adults were specifically targeted because they represent a high-risk group with both a higher prevalence of vitamin D deficiency and an increased burden of cardiometabolic disorders. In addition, age-related physiological changes, such as reduced cutaneous synthesis of vitamin D and alterations in body composition, may influence both vitamin D status and metabolic health.

By applying complex sample analyses to population-based data, this study sought to provide a comprehensive evaluation of these associations and to clarify the relationship between vitamin D deficiency and key metabolic pathways in older populations.

2. Materials and Methods

2.1. Study Design and Data Source

This study employed a cross-sectional design using data from the Korea National Health and Nutrition Examination Survey (KNHANES). The dataset used in this study was collected in 2024 and released in December 2025. KNHANES is a nationally representative surveillance system of the non-institutionalized Korean population and has been conducted as an annual survey using a complex, multistage probability sampling design to generate nationally representative health and nutrition statistics in Republic of Korea. More recent overviews have also highlighted the continued expansion and public availability of KNHANES data resources [14].

KNHANES collects data through standardized health interviews, health examinations, and laboratory tests conducted by trained personnel. In the present study, all variables were extracted from the KNHANES dataset. Sociodemographic characteristics and health behavior variables were obtained from self-reported questionnaires, whereas anthropometric measures and metabolic biomarkers were based on direct physical examination and laboratory assessment.

2.2. Study Participants

Among the 6997 participants included in the 2024 KNHANES dataset, individuals aged 65 years or older were considered eligible for this study (n = 1951). Participants were included if they had available data on serum vitamin D levels and all relevant metabolic biomarkers. Individuals with missing values for key variables, including vitamin D, metabolic biomarkers, or covariates, were excluded from the analysis. After applying these criteria, a total of 1806 participants were included in the final analytic sample. All analyses incorporated sampling weights to account for the complex survey design and to ensure nationally representative estimates.

2.3. Vitamin D Status

The main independent variable was vitamin D status. Serum vitamin D concentration was assessed using 25-hydroxyvitamin D [25(OH)D], which is the accepted biomarker for evaluating vitamin D status. Vitamin D deficiency was defined as a serum 25(OH)D level < 20 ng/mL. This threshold remains widely used in recent vitamin D literature, although recent guidelines have noted that the optimal target concentration for disease prevention remains under debate. Participants were categorized into vitamin D-deficient and non-deficient groups accordingly [15].

2.4. Metabolic Biomarkers

The dependent variables included fasting glucose (mg/dL), glycated hemoglobin (HbA1c, %), triglycerides (mg/dL), C-reactive protein (CRP, mg/L), high-density lipoprotein cholesterol (HDL-C, mg/dL), waist circumference (cm), and body mass index (BMI, kg/m2). Laboratory biomarkers were obtained from blood samples collected and analyzed by KNHANES using standardized procedures, and fasting glucose and triglycerides were based on fasting blood samples. Anthropometric variables, including waist circumference, height, and weight, were measured directly by trained personnel using standardized protocols. BMI was calculated as weight in kilograms divided by height in meters squared.

These biomarkers are commonly used indicators of metabolic and cardiometabolic risk in older adults. Because triglycerides and C-reactive protein exhibited skewed distributions, natural logarithmic transformation was applied prior to analysis to improve normality.

2.5. Covariates

Covariates included sociodemographic characteristics, health behaviors, and comorbid conditions. Sociodemographic variables included age (years), sex (male/female), residence (urban/rural), household income, and education level. Residence was categorized as urban or rural based on administrative classification. Household income was categorized into quartiles (Q1: Q4) based on the KNHANES household income quartile variable, which is derived from monthly equivalized household income (monthly household income divided by the square root of household size). Education level was categorized as ≤elementary school, middle school, high school, or ≥college.

Health behavior variables included monthly alcohol consumption, current smoking status, and aerobic physical activity. These variables were assessed using self-reported questionnaires. Monthly alcohol consumption was defined as drinking alcohol at least once per month (yes/no), and current smoking status was categorized as yes or no. Aerobic physical activity was defined according to KNHANES guidelines as engaging in at least 150 min of moderate-intensity physical activity or 75 min of vigorous-intensity physical activity per week, or an equivalent combination of both.

Comorbidities included hypertension and diabetes mellitus, which were defined based on physician diagnosis, current treatment, or standardized KNHANES criteria. These variables were selected as potential confounders based on previous studies demonstrating their associations with both vitamin D status and metabolic risk [16,17].

Obesity: and inflammation-related variables, including body mass index, waist circumference, and C-reactive protein, were not included as covariates because they were analyzed as outcome variables in this study. Including these variables as covariates could result in over-adjustment and potentially obscure the associations of interest.

2.6. Statistical Analysis

All statistical analyses were performed using IBM SPSS Statistics (version 29.0, IBM Corp., Armonk, NY, USA), applying complex sample design procedures to account for the stratification, clustering, and sampling weights of KNHANES. These procedures were used to generate nationally representative estimates and appropriate standard errors reflecting the multistage probability sampling design. Descriptive statistics were presented as weighted percentages with standard errors (SE) for categorical variables and weighted means with SE for continuous variables. Differences in participant characteristics according to vitamin D status were assessed using the Rao: Scott chi-square test for categorical variables and complex sample general linear models for continuous variables.

To examine the association between vitamin D status and metabolic biomarkers, complex sample linear regression analyses were conducted, with vitamin D status included as a dichotomous independent variable (deficient vs. non-deficient) and metabolic biomarkers treated as continuous dependent variables. Model 1 was unadjusted. Model 2 was adjusted for sociodemographic variables (age, sex, residence, household income, and education level). Model 3 was additionally adjusted for health behaviors (smoking, alcohol consumption, and aerobic physical activity) and comorbidities (hypertension and diabetes mellitus). The results were presented as β coefficients, 95% confidence intervals (CI), and p-values.

Statistical significance was set at p < 0.05.

2.7. Ethical Considerations

KNHANES was conducted by the Korea Disease Control and Prevention Agency (KDCA) in accordance with the Declaration of Helsinki and was approved by the KDCA Institutional Review Board (IRB No. 2022-11-16-R-03). Written informed consent was obtained from all participants during the original survey. The present study was based on a secondary analysis of publicly available KNHANES data collected in 2024 and released in December 2025. Because the dataset was fully de-identified and contained no personally identifiable information, additional institutional review board approval was not required for this study.

3. Results

3.1. General Characteristics of Participants

The general characteristics of the study population are presented in Table 1. A total of 1806 older adults were included, with a mean age of 72.78 ± 0.18 years. Women accounted for 54.0% of the sample, and 73.8% resided in urban areas. Socioeconomically, 37.2% were in the lowest household income quartile, and 43.1% had an education level of elementary school or lower. In terms of health behaviors, 64.7% reported no monthly alcohol consumption, 91.9% were non-smokers, and 67.6% did not engage in aerobic physical activity.

The prevalence of hypertension and diabetes mellitus was 54.0% and 24.8%, respectively. The mean serum vitamin D level was 29.88 ± 0.38 ng/mL. The mean fasting glucose level was 107.42 ± 0.57 mg/dL, and the mean HbA1c was 5.97 ± 0.02%. The mean HDL-cholesterol level was 56.41 ± 0.41 mg/dL, and the mean waist circumference was 85.69 ± 0.27 cm (Table 1).

3.2. Differences in Characteristics According to Vitamin D Status

Among the study population, 409 participants (22.6%) were classified as vitamin D deficient. Differences in participant characteristics according to vitamin D status are presented in Table 2. Compared with participants without vitamin D deficiency, those with deficiency were older and more likely to be male. They also had a higher prevalence of current smoking and diabetes mellitus and were less likely to engage in aerobic physical activity. In terms of metabolic profiles, participants with vitamin D deficiency showed less favorable profiles, including higher fasting glucose, HbA1c, triglycerides, and waist circumference, as well as lower HDL-cholesterol levels.

No significant differences were observed for residence, household income, education level, monthly alcohol consumption, hypertension, or body mass index.

3.3. Association Between Vitamin D Deficiency and Metabolic Biomarkers

The associations between vitamin D deficiency and metabolic biomarkers are presented in Table 3. In the unadjusted model, vitamin D deficiency was associated with higher levels of fasting glucose, HbA1c, triglycerides, and waist circumference, and with lower HDL-cholesterol levels. After adjustment for sociodemographic factors, the associations remained significant for HbA1c, triglycerides, and waist circumference, whereas those for fasting glucose and HDL-cholesterol were attenuated. In the fully adjusted model, vitamin D deficiency remained significantly associated with higher HbA1c (β = 0.10, 95% CI: 0.01 to 0.20, p = 0.034), higher triglyceride levels (β = 0.10, 95% CI: 0.04 to 0.17, p = 0.003), and greater waist circumference (β = 1.21, 95% CI: 0.06 to 2.37, p = 0.040).

No significant associations were observed for fasting glucose, HDL-cholesterol, C-reactive protein, or body mass index. Detailed regression coefficients are presented in Table 3.

4. Discussion

This study aimed to examine the association between vitamin D deficiency and multiple metabolic biomarkers in a nationally representative sample of older adults. The main findings showed that vitamin D deficiency remained independently associated with higher HbA1c, triglyceride levels, and waist circumference after full adjustment, whereas the associations with fasting glucose, HDL-cholesterol, C-reactive protein, and body mass index were no longer significant. These findings suggest that the metabolic correlates of vitamin D deficiency in later life may be selective rather than uniform across cardiometabolic markers.

In particular, vitamin D deficiency appeared to be more closely related to markers of long-term glycemic control, triglyceride metabolism, and central adiposity than to other metabolic domains.

One notable finding was that vitamin D deficiency remained associated with HbA1c, but not with fasting glucose, in the fully adjusted model. This distinction suggests that vitamin D status may be more closely related to long-term glycemic regulation than to short-term glucose fluctuations. This interpretation is supported by recent intervention evidence showing that vitamin D supplementation can improve glycemic control in type 2 diabetes, including HbA1c-related outcomes, although the magnitude of benefit varies across studies [18]. In addition, an updated 2024 systematic review and meta-analysis in older adults reported that low 25(OH)D was associated with incident diabetes even after adjustment for relevant confounders, supporting the view that low vitamin D status is linked to poorer long-term glycemic health in aging populations [19].

From a pathophysiological perspective, vitamin D may influence chronic glycemic status through its role in pancreatic β-cell function, calcium-mediated insulin secretion, and systemic insulin sensitivity [20]. In contrast, fasting glucose is a single-time-point measure and may be more sensitive to recent metabolic conditions, fasting-related variability, and circadian timing than HbA1c [21]. HbA1c, by contrast, reflects average glycemic exposure over approximately 8 to 12 weeks [22]. Therefore, the discrepancy observed in the present study may reflect differences in the temporal characteristics of glycemic markers rather than inconsistency in biological effects.

Taken together, the present HbA1c finding appears consistent with prior evidence. In contrast, the null finding for fasting glucose may indicate that vitamin D status is more closely related to cumulative glycemic exposure than to a single fasting measurement. Given the clinical importance of glycemic control in older adults, the observed association with HbA1c may be clinically meaningful [23].

The association with triglycerides is also consistent with previous findings. A 2024 systematic review and meta-analysis of randomized controlled trials in people with type 2 diabetes concluded that vitamin D supplementation improved triglyceride and HDL levels, while not significantly improving LDL or total cholesterol [24]. Likewise, a 2025 meta-analysis in overweight or obese women reported a significant effect of vitamin D supplementation on hypertriglyceridemia, but not on LDL-C [25]. In the present study, however, only triglycerides remained significant after full adjustment, whereas HDL-cholesterol did not.

This divergence suggests that vitamin D deficiency may be preferentially linked to triglyceride metabolism rather than to all lipid fractions. Mechanistically, triglycerides are closely associated with insulin resistance and hepatic lipid synthesis, both of which have been proposed as pathways influenced by vitamin D status. In contrast, HDL-cholesterol is affected by a broader range of genetic, hormonal, and lifestyle factors, which may attenuate its independent association with vitamin D after adjustment. Therefore, the present findings support a more targeted interpretation of vitamin D in lipid metabolism, emphasizing its potential role in triglyceride regulation.

Another important finding was that vitamin D deficiency was associated with waist circumference, but not with body mass index, after adjustment. This distinction highlights the need to differentiate between central adiposity and general obesity in older populations. A 2025 cross-sectional study in older adults demonstrated that serum vitamin D levels were inversely associated with visceral adipose tissue mass, a metabolically active fat compartment strongly linked to insulin resistance and cardiometabolic risk [26]. That study further reported attenuation of the association after adjustment, indicating that adiposity-related relationships are influenced by multiple confounding variables [26].

In the present study, the persistence of waist circumference but not BMI suggests that vitamin D deficiency may be more closely related to abdominal fat distribution than to overall body mass. This finding is particularly relevant in older adults, where age-related changes such as sarcopenia and fat redistribution may limit the interpretability of BMI. Waist circumference, as a marker of central adiposity, may therefore provide a more sensitive indicator of metabolically relevant fat accumulation in this population.

By contrast, the loss of significance for fasting glucose, HDL-cholesterol, and C-reactive protein after multivariable adjustment suggests that the crude associations observed in unadjusted analyses were at least partly explained by confounding variables. Factors such as age, physical activity, smoking, and comorbid conditions are known to influence both vitamin D status and metabolic health, and their inclusion in the adjusted models likely reduced spurious associations. This interpretation is consistent with recent literature showing that vitamin D supplementation may influence inflammatory markers in specific populations rather than uniformly across all adults [27].

Therefore, the absence of an independent association with C-reactive protein in the present study should be interpreted cautiously and may reflect the influence of confounding factors rather than the absence of any relationship. The lack of significant associations for several biomarkers after full adjustment further suggests that the crude relationships observed in unadjusted analyses may have been influenced by confounding factors, highlighting the importance of appropriate adjustment in epidemiological studies.

The cross-sectional design of this study requires cautious interpretation of the observed associations. A 2025 bidirectional two-sample Mendelian randomization study found no evidence that circulating 25(OH)D is linked to metabolic syndrome traits in a directional manner; instead, it suggested that vitamin D status and metabolic traits such as waist circumference, BMI, and triglycerides may be interrelated [28]. This finding is relevant to the present study, as it suggests that the observed associations may reflect complex or bidirectional relationships rather than a simple one-way pathway between vitamin D deficiency and metabolic dysfunction.

Taken together, these findings suggest that vitamin D deficiency may be linked to specific aspects of metabolic dysregulation: particularly long-term glycemic control, triglyceride metabolism, and central adiposity: while other associations may be partly influenced by confounding variables. This domain-specific pattern may help explain the heterogeneity observed in previous studies and highlights the need for more targeted investigation of vitamin D-related metabolic pathways. In addition, renal function, which plays an important role in vitamin D metabolism, was not included in the present analysis; therefore, residual confounding variables cannot be excluded.

Furthermore, seasonal variation in vitamin D levels was not explicitly accounted for in this study. Although KNHANES employs a year-round rolling survey design, differences in sunlight exposure across seasons may have influenced serum vitamin D concentrations, and thus residual confounding variables related to seasonality may remain. Future studies incorporating kidney function indicators and seasonal adjustment are warranted to better clarify these relationships.

Overall, the present findings should be interpreted cautiously. In this nationally representative sample of older adults, vitamin D deficiency was independently associated with HbA1c, triglycerides, and waist circumference, but not with fasting glucose, HDL-cholesterol, C-reactive protein, or body mass index after full adjustment. These findings are consistent with previous evidence suggesting that the associations between vitamin D deficiency and metabolic markers may differ according to the specific outcome examined.

5. Conclusions

Vitamin D deficiency was independently associated with higher HbA1c, triglyceride levels, and waist circumference in older adults, but not with fasting glucose, HDL-cholesterol, C-reactive protein, or body mass index after adjustment. These findings suggest that the associations between vitamin D deficiency and metabolic markers in older adults may differ according to the specific biomarker examined. Future longitudinal and interventional studies are needed to clarify the directionality and underlying mechanisms of these associations.

Acknowledgments

During the preparation of this manuscript, the authors used ChatGPT (OpenAI, GPT-5.3) for language editing and proofreading. The authors reviewed and edited the output and take full responsibility for the content of this publication.

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Author Contributions

Conceptualization, K.J.; methodology, K.J.; formal analysis, K.J.; investigation, Y.-J.K.; data curation, Y.-J.K.; writing: original draft preparation, Y.-J.K.; writing: review and editing, K.J.; visualization, Y.-J.K.; supervision, K.J.; project administration, K.J. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Korea Disease Control and Prevention Agency (KDCA) (protocol code 2022-11-16-R-03, approval date: 16 November 2022).

Informed Consent Statement

Patient consent was waived because the present study used data from the Korea National Health and Nutrition Examination Survey (KNHANES), which is a nationally representative dataset managed by the Korean government. All participants in KNHANES provided informed consent at the time of data collection, and the survey procedures were conducted under the approval of the relevant Institutional Review Board (IRB).

Data Availability Statement

The data used in this study are publicly available from the Korea National Health and Nutrition Examination Survey (KNHANES) and can be accessed at https://knhanes.kdca.go.kr (accessed on 28 March 2026) upon reasonable request and approval by the Korea Disease Control and Prevention Agency.

Conflicts of Interest

The author declares no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript: 25(OH)D25-hydroxyvitamin DBMIbody mass indexCIconfidence intervalCRPC-reactive proteinHbA1cglycated hemoglobinHDL-Chigh-density lipoprotein cholesterolIBMInternational Business MachinesIRBInstitutional Review BoardKDCAKorea Disease Control and Prevention AgencyKNHANESKorea National Health and Nutrition Examination SurveySEstandard errorSPSSStatistical Package for the Social Sciences

References

1. Pedretti R.F.E. Asteggiano R. Gevaert A.B. Bowen T.S. Caselli S. Cornelissen V.A. Christodorescu R. Derosa G. Dievart F. Kurpas D. Cardiovascular risk factors management in older adults: A clinical consensus statement from the European Association of Preventive Cardiology of the ESC and the ESC Council for Cardiology Practice Eur. J. Prev. Cardiol. 2025 zwaf175 10.1093/eurjpc/zwaf175 40795065
2. Rhee E.J. Prevalence and current status of cardiometabolic risk factors in Korean adults based on fact sheets 2024 Endocrinol. Metab. 2025 40 174 184 10.3803/EnM.2025.2398 PMC12061748 40312986
3. Kim H.-J. Kang D.R. Kim J.Y. Kim W. Jeong Y.W. Chun K.-H. Han S.H. Koh K.K. on behalf of the Taskforce Team of the Metabolic Syndrome Fact Sheet of the Korean Society of Cardiometabolic Syndrome Metabolic syndrome fact sheet 2024: Executive report CardioMetabolic Syndr. J. 2024 4 70 80 10.51789/cmsj.2024.4.e14
4. Bays H.E. Kirkpatrick C.F. Maki K.C. Toth P.P. Morgan R.T. Tondt J. Christensen S.M. Dixon D.L. Jacobson T.A. Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association J. Clin. Lipidol. 2024 18 e320 e350 10.1016/j.jacl.2024.04.001 38664184
5. Sarkar S. Prasanna V.S. Das P. Suzuki H. Fujihara K. Kodama S. Sone H. Sreedhar R. Velayutham R. Watanabe K. The onset and the development of cardiometabolic aging: An insight into the underlying mechanisms Front. Pharmacol. 2024 15 1447890 10.3389/fphar.2024.1447890 39391689 PMC11464448
6. Młynarska E. Lisińska W. Hossa K. Krupińska N. Jakubowska P. Rysz J. Franczyk B. Vitamin D and chronic disorders: A review of metabolic and cardiovascular diseases Pharmaceuticals 2025 18 1467 10.3390/ph18101467 41155582 PMC12567385
7. Cimini F.A. Sentinelli F. Oldani A. Barchetta I. Cavallo M.G. Adipose tissue dysfunction and metabolic diseases: The role of vitamin D/vitamin D receptor axis Int. J. Mol. Sci. 2025 26 10256 10.3390/ijms262110256 41226298 PMC12610601
8. Zhang N. Wang Y. Li W. Wang Y. Zhang H. Xu D. Chen R. Tang L. Tang H. Association between serum vitamin D level and cardiovascular disease in Chinese patients with type 2 diabetes mellitus: A cross-sectional study Sci. Rep. 2025 15 6454 10.1038/s41598-025-90785-8 39987347 PMC11846893
9. Shu M. Xi Y. Wu J. Zhuo L.-B. Yan Y. Yang Y.-D. Feng Y.-Y. Tan H.-Q. Yang H.-F. Chen Y.-M. Relationship between circulating 25-hydroxyvitamin D and metabolic syndrome in Chinese adults: A nationwide longitudinal study Nutrients 2024 16 1480 10.3390/nu16101480 38794718 PMC11124364
10. Lee C. Jang K. Vitamin D, C-reactive protein, and cardiometabolic risk clustering in middle-aged adults: Results from the 2023 Korea National Health and Nutrition Examination Survey Biomedicines 2025 13 2762 10.3390/biomedicines13112762 41301855 PMC12650019
11. Argano C. Mirarchi L. Amodeo S. Orlando V. Torres A. Corrao S. The role of vitamin D in insulin resistance, diabetes, metabolic syndrome, and cardiovascular disease Int. J. Mol. Sci. 2023 24 15485 10.3390/ijms242015485 37895163 PMC10607188
12. Molani-Gol R. Rafraf M. Safari S. Effects of vitamin D supplementation on metabolic parameters, anthropometric measures, and diabetes risk in patients with prediabetes: An umbrella review of meta-analyses of randomized controlled trials Nutr. Metab. 2025 22 99 10.1186/s12986-025-00994-1 PMC12351829 40813680
13. Lei X. Zhou Q. Wang Y. Fu S. Li Z. Chen Q. Serum and supplemental vitamin D levels and insulin resistance in T2DM populations: A meta-analysis and systematic review Sci. Rep. 2023 13 12343 10.1038/s41598-023-39469-9 37524765 PMC10390579
14. Oh K. Kim Y. Kweon S. Kim S. Yun S. Park S. Lee Y.-K. Kim Y.-T. Park O. Jeong E.K. Korea National Health and Nutrition Examination Survey, 20th anniversary: Accomplishments and future directions Epidemiol. Health 2021 43 e2021025 10.4178/epih.e2021025 33872484 PMC8289475
15. Demay M.B. Pittas A.G. Bikle D.D. Diab D.L. Kiely M.E. Lazaretti-Castro M. Lips P. Mitchell D.M. Murad M.H. Powers S. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab. 2024 109 1907 1947 10.1210/clinem/dgae290 38828931
16. Contreras-Bolívar V. García-Fontana B. García-Fontana C. Muñoz-Torres M. Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice Nutrients 2021 13 3491 10.3390/nu13103491 34684492 PMC8539968
17. Melguizo-Rodríguez L. Costela-Ruiz V.J. García-Recio E. De Luna-Bertos E. Ruiz C. Illescas-Montes R. Role of vitamin D in the metabolic syndrome Nutrients 2021 13 830 10.3390/nu13030830 33802330 PMC7999005
18. Afraie M. Bahrami P. Kohnepoushi P. Khateri S. Majidi L. Saed L. Zamani K. Baharm H.M. Moradi Y. Moradpour F. The Effect of Vitamin D Supplementation on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Clinical Trials J. Diabetes Res. 2024 2024 9960656 10.1155/2024/9960656 39290798 PMC11407890
19. Dominguez L.J. Veronese N. Marrone E. Di Palermo C. Iommi C. Ruggirello R. Caffarelli C. Gonnelli S. Barbagallo M. Vitamin D and Risk of Incident Type 2 Diabetes in Older Adults: An Updated Systematic Review and Meta-Analysis Nutrients 2024 16 1561 10.3390/nu16111561 38892495 PMC11173817
20. Meng X. Yang X. Lu H. Yang X. Hu D. Wu H. Vitamin D and Its Regulatory Role in Pancreatic β-Cell Function: Implications for Diabetes Diabetes Metab. Syndr. Obes. 2025 18 4741 4754 10.2147/DMSO.S551390 41459328 PMC12743462
21. Alum E.U. Circadian nutrition and obesity: Timing as a nutritional strategy J. Health Popul. Nutr. 2025 44 367 10.1186/s41043-025-01102-y 41107910 PMC12535013
22. Mehta M. Prasad A. Kalapureddy V. Narayanam H. Kondaveeti S.B. “Insights into HbA1c: Key Role in Diabetes Screening and Associated Conditions”: A Comprehensive Review J. Pharm. Bioallied Sci. 2025 17 S1064 S1066 10.4103/jpbs.jpbs_1631_24 40655791 PMC12244728
23. Jang K. Factors influencing glycemic control in older adults with diabetes in South Korea: Analysis using the 2022 KNHANES data J. Gerontol. Nurs. 2025 51 30 37 10.3928/00989134-20250812-01 40825186
24. Lu Q. Liang Q. Xi Y. The effects of vitamin D supplementation on serum lipid profiles in people with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials Front. Nutr. 2024 11 1419747 10.3389/fnut.2024.1419747 38903615 PMC11188582
25. Hu L. Velu P. Prabahar K. Hernández-Wolters B. Kord-Varkaneh H. Xu Y. Vitamin D and lipid profile in obesity Nutr. Rev. 2025 83 1657 1668 10.1093/nutrit/nuae226 39873663
26. Behnamzade M. Adabi R. Ashrafpour M. Ghadimi R. Bijani A. Hosseini S.R. Association Between Serum Vitamin D Levels and Visceral Adipose Tissue in Older Adults in Iran: A Cross-Sectional Study From the Amirkola Health and Aging Project Clin. Nutr. Res. 2025 14 308 317 10.7762/cnr.2025.14.4.308 41267915 PMC12629407
27. Jiang Q. Prabahar K. Saleh S.A.K. Adly H.M. Velu P. Adi A.R. Baradwan S. Hajkhalaf M.I. Baredwan A. Gari F. The Effects of Vitamin D Supplementation on C-Reactive Protein and Systolic and Diastolic Blood Pressure in Postmenopausal Women: A Meta-Analysis and Systematic Review of Randomized Controlled Trials J. Acad. Nutr. Diet. 2024 124 387 396 10.1016/j.jand.2023.10.013 38441080
28. Lee Y. Seo J.H. Lee J. Kim H.S. Causal Effects of 25-Hydroxyvitamin D on Metabolic Syndrome and Metabolic Risk Traits: A Bidirectional Two-Sample Mendelian Randomization Study Biomedicines 2025 13 723 10.3390/biomedicines13030723 40149699 PMC11940704
Table 1

General characteristics of participants (n = 1806).

VariableCategory n Weighted % or Mean ± SE95% CI
Sociodemographic
Age, yearsNot reported180672.78 ± 0.1872.43 to 73.14
SexMale76046.0 ± 1.143.9 to 48.1
Female104654.0 ± 1.151.9 to 56.1
ResidenceUrban127373.8 ± 3.666.0 to 80.4
Rural53326.2 ± 3.619.6 to 34.0
Household incomeQ1 (lowest)73737.2 ± 1.833.8 to 40.8
Q253731.4 ± 1.528.5 to 34.5
Q334820.2 ± 1.417.5 to 23.2
Q4 (highest)18411.2 ± 1.09.3 to 13.4
Education level≤Elementary80343.1 ± 1.739.8 to 46.5
Middle37320.5 ± 1.118.5 to 22.7
High41224.0 ± 1.221.7 to 26.5
≥College21812.4 ± 1.210.1 to 15.0
Health behaviors
Monthly drinkingNo118664.7 ± 1.461.9 to 67.5
Yes62035.3 ± 1.432.5 to 38.1
Current smokingNo162991.9 ± 0.790.3 to 93.2
Yes1778.1 ± 0.76.8 to 9.7
Aerobic physical activityNo121867.6 ± 1.764.1 to 70.9
Yes58832.4 ± 1.729.1 to 35.9
Comorbidities
HypertensionNo82346.0 ± 1.343.3 to 48.6
Yes98354.0 ± 1.351.3 to 56.6
Diabetes mellitusNo135875.1 ± 1.172.9 to 77.2
Yes44824.8 ± 1.122.8 to 27.0
Metabolic and clinical variables
Vitamin D, ng/mLNot reported180629.88 ± 0.3829.13 to 30.64
Fasting glucose, mg/dLNot reported1806107.42 ± 0.57106.30 to 108.54
HbA1c, %Not reported18065.97 ± 0.025.92 to 6.01
ln (Triglycerides)Not reported18064.68 ± 0.014.66 to 4.71
ln (C-reactive protein)Not reported1806−0.51 ± 0.03−0.56 to −0.46
HDL-cholesterol, mg/dLNot reported180656.41 ± 0.4155.60 to 57.21
Waist circumference, cmNot reported180685.69 ± 0.2785.17 to 86.21
Body mass index, kg/m2Not reported180624.07 ± 0.0923.90 to 24.24

Note. Values are presented as weighted percentages with standard errors (SE) for categorical variables and weighted means with SE for continuous variables, along with 95% confidence intervals (CI), using a complex sample design. Unweighted frequencies are presented as n. Household income quartiles were defined according to the 2024 KNHANES household income quartile criteria based on monthly equivalized household income: Q1, ≤129.64; Q2, 129.65 to 264.89; Q3, 264.90 to 418.34; and Q4, >418.34 (10,000 KRW/month). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values.

Abbreviations: SE, standard error; CI, confidence interval; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Table 2

Comparison of characteristics according to vitamin D status.

VariableCategoryDeficient
(<20 ng/mL,
n = 409)
Non-Deficient
(≥20 ng/mL,
n = 1397)
F p
Sociodemographic factors
Age, yearsNot reported73.37 ± 0.3472.61 ± 0.184.960.026
SexMale63.4 (1.8)40.9 (1.2)55.35<0.001
Female36.6 (1.8)59.1 (1.2)
ResidenceUrban74.7 (2.0)73.6 (1.4)0.100.748
Rural25.3 (2.0)26.4 (1.4)
Household incomeQ138.4 (2.5)36.9 (1.7)0.550.643
Q232.4 (2.2)31.1 (1.5)
Q317.7 (1.7)20.9 (1.3)
Q411.5 (1.3)11.1 (1.0)
Education level≤Elementary43.0 (2.4)43.1 (1.6)0.330.788
Middle19.0 (1.8)20.9 (1.3)
High24.3 (2.0)23.9 (1.4)
≥College13.7 (1.5)12.0 (1.0)
Health behaviors
Monthly drinkingNo61.0 (2.4)65.8 (1.5)2.570.111
Yes39.0 (2.4)34.2 (1.5)
Current smokingNo85.4 (1.7)93.8 (0.8)22.77<0.001
Yes14.6 (1.7)6.2 (0.8)
Aerobic physical activityNo73.7 (2.1)65.9 (1.6)5.480.020
Yes26.3 (2.1)34.1 (1.6)
Comorbidities
HypertensionNo45.7 (2.4)46.1 (1.6)0.130.872
Yes54.3 (2.4)53.9 (1.6)
Diabetes mellitusNo72.1 (2.1)76.1 (1.3)3.270.040
Yes27.9 (2.1)23.9 (1.3)
Metabolic and clinical variables
Waist circumference, cmNot reported87.26 ± 0.6485.23 ± 0.3111.65<0.001
Body mass index, kg/m2Not reported24.27 ± 0.1524.01 ± 0.102.210.139
HDL-cholesterol, mg/dLNot reported52.01 ± 0.7757.69 ± 0.4839.58<0.001
Fasting glucose, mg/dLNot reported110.68 ± 1.46106.47 ± 0.616.700.010
HbA1c, %Not reported6.08 ± 0.055.93 ± 0.028.500.004
ln (Triglycerides)Not reported4.79 ± 0.034.66 ± 0.0115.00<0.001
ln (C-reactive protein)Not reported−0.31 ± 0.06−0.57 ± 0.0316.00<0.001

Note. Values are presented as weighted percentages (SE) for categorical variables and weighted means (SE) for continuous variables. The Rao: Scott chi-square test (reported as adjusted F statistics) was used for categorical variables, and complex samples general linear models were used for continuous variables. Household income quartiles were defined according to the 2024 KNHANES household income quartile criteria based on monthly equivalized household income: Q1, ≤129.64; Q2, 129.65 to 264.89; Q3, 264.90 to 418.34; and Q4, >418.34 (10,000 KRW/month). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values.

Abbreviations: HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Table 3

Association between vitamin D deficiency and metabolic biomarkers in older adults.

OutcomeModel 1
β (95% CI)
p Model 2
β (95% CI)
p Model 3
β (95% CI)
p
Fasting glucose (mg/dL)4.21 (1.04, 7.39)0.0102.87 (−0.34, 6.07)0.0792.17 (−1.01, 5.35)0.180
HbA1c (%)0.15 (0.05, 0.25)0.0040.14 (0.04, 0.24)0.0080.10 (0.01, 0.20)0.034
ln (Triglycerides)0.13 (0.07, 0.19)<0.0010.12 (0.06, 0.19)<0.0010.10 (0.04, 0.17)0.003
ln (C-reactive protein)0.06 (−0.03, 0.15)0.1960.05 (−0.04, 0.14)0.2760.04 (−0.05, 0.13)0.391
HDL-cholesterol (mg/dL)−1.87 (−3.22, −0.52)0.007−1.21 (−2.58, 0.16)0.083−0.89 (−2.21, 0.43)0.186
Waist circumference (cm)2.03 (0.85, 3.20)<0.0011.54 (0.36, 2.72)0.0111.21 (0.06, 2.37)0.040
Body mass index (kg/m2)0.25 (−0.08, 0.59)0.1390.19 (−0.15, 0.52)0.2730.12 (−0.21, 0.45)0.471

Note. Model 1 was unadjusted. Model 2 was adjusted for age, sex, residence, household income, and education level. Model 3 was additionally adjusted for smoking, alcohol consumption, aerobic physical activity, hypertension, and diabetes mellitus. β coefficients represent differences in metabolic biomarker levels for participants with vitamin D deficiency (<20 ng/mL) compared with those without deficiency (≥20 ng/mL). Triglycerides and C-reactive protein were log-transformed due to skewed distributions and are presented as ln-transformed values. All analyses were conducted using complex sample design procedures.

Abbreviations: CI, confidence interval; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; ln, natural logarithm.

Publication and source details

Original title: Association Between Vitamin D Deficiency and Glycemic, Lipid, and Adiposity Markers in Older Adults: A Nationally Representative Study

Yong-Joon Kim; Kyeongmin Jang

Metabolites · 2026

* Correspondence: kyeongmin@daejin.ac.kr; Tel.: +82-31-539-1879© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:25:23.972478+00:00

DOI: 10.3390/metabo16040270 · PMC13118007